Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis
Authors:
- Vijay BodukamVBVijay Bodukam
- Ron D. HaysRHRon D. Hays
- Paul MaranianPMPaul Maranian
- Daniel E. FurstDFDaniel E. Furst
- James R. SeiboldJSJames R. Seibold
- Ann ImpensAIAnn Impens
- Maureen D. MayesMMMaureen D. Mayes
- Philip J. ClementsPCPhilip J. Clements
- Dinesh KhannaDKDinesh Khanna
Open Access
- 30 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (2) , 330-334
Abstract
Objectives. SSc-associated gastrointestinal tract involvement (SSc-GIT) is an important predictor of depressive symptoms. University of California at Los Angeles Scleroderma Clinical trial Consortium Gastrointestinal Tract 2.0 (UCLA SCTC GIT 2.0) is a 34-item valid instrument that captures GIT symptom severity and impact on quality of life. It has seven GI-specific scales and a total GIT score. The objectives were to assess: (i) whether there is an association between depressed mood with GI symptom scales as assessed by the UCLA SCTC GIT 2.0 instrument; and (ii) to explore which GI-specific symptom scales are associated with depressed mood in patients with SSc. Methods. One hundred and fifty-two patients with SSc completed the UCLA SCTC GIT 2.0 and the Center for Epidemiologic Studies Short Depression scale (CES-D10). Patients were divided into depressed (CES-D ≥ 10) or non-depressed group (CES-D < 10) and compared using t-test or chi-square test. Multiple linear regression was used to determine associations between GI scales and depressed mood (CES-D). Results. Study participants were 84% female, 78% Caucasian and 40% had depressed mood (CES-D10 ≥ 10). Patients with depressed mood had statistically worse GI scale scores (except fecal soilage) and worse total GIT score (P < 0.05). In the multivariable model reflux and constipation scales were independently associated with worse CES-D scores (P = 0.01–0.06) Conclusion. SSc-GIT involvement is associated with depressed mood. Reflux and constipation scales of UCLA-SCTC GIT 2.0 were independently associated with CES-D. Future studies should assess if treatment of GIT symptoms will improve depressed mood in patients with SSc-GIT.Keywords
This publication has 10 references indexed in Scilit:
- Depression, Anxiety and Anger in Subtypes of Irritable Bowel Syndrome PatientsJournal of Clinical Psychology in Medical Settings, 2010
- Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrumentArthritis Care & Research, 2009
- Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosisArthritis Care & Research, 2008
- Chapter 5 Gastrointestinal Involvement in Systemic Sclerosis2008
- Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrumentArthritis Care & Research, 2007
- Depression in patients with systemic sclerosis: A systematic review of the evidenceArthritis Care & Research, 2007
- Severe gastro‐oesophageal reflux symptoms in relation to anxiety, depression and coping in a population‐based studyAlimentary Pharmacology & Therapeutics, 2007
- Health values of patients with systemic sclerosisArthritis Care & Research, 2007
- Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis.2005
- Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiativeAlimentary Pharmacology & Therapeutics, 2003